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ABSTRACT
Telomere length homeostasis, critical for chromosomal integrity and genome 
stability, is controlled by intricate molecular regulatory machinery that includes 
epigenetic modifications. Here, we examine site-specific and spatiotemporal alteration 
of the subtelomeric methylation of CpG islands using optogenetic tools to understand 
the epigenetic regulatory mechanisms of telomere length maintenance. Human DNA 
methyltransferase3A (DNMT3A) were assembled selectively at chromosome ends 
by fusion to cryptochrome 2 protein (CRY2) and its interacting complement, the 
basic helix loop helix protein-1 (CIB1). CIB1 was fused to the telomere-associated 
protein telomere repeat binding factor-1 (TRF1), which localized the protein complex 
DNMT3A-CRY2 at telomeric regions upon excitation by blue-light monitored by single-
molecule fluorescence analyses. Increased methylation was achieved selectively at 
subtelomeric CpG sites on the six examined chromosome ends specifically after blue-
light activation, which resulted in progressive increase in telomere length over three 
generations of HeLa cell replications. The modular design of the fusion constructs 
presented here allows for the selective substitution of other chromatin modifying 
enzymes and for loci-specific targeting to regulate the epigenetic pathways at 
telomeres and other selected genomic regions of interest.
INTRODUCTION
Telomeres disguise chromosome ends preventing 
aberrant double strand break repair [1]. The defects in 
telomere maintenance cause end-to-end chromosome 
(telomere) fusions, which are well known sources of 
genomic instability and subsequent cancer development 
[2-4]. Additionally, telomere fusions and stochastic 
breakage-fusion cycles caused by dysfunctional telomeres 
are considered a likely source of genomic heterogeneity 
seen in many human cancers [5, 6]. More specifically, 
telomeres are specialized nucleoprotein complexes 
composed of multiple arrays of duplex TTAGGG repeats 
and a variety of telomere-associated proteins [1, 7]. 
Telomere repeat binding factor-1 (TRF1) and 2 (TRF2) 
along with TIN2, POT1, TPP1 and RAP1 form the 
shelterin complex, which cap or protect the chromosome 
ends from deleterious telomere fusions [7-10]. TRF1 
binds directly to telomeric and subtelomeric interstitial 
TTAGGG repeat sequences as a homodimer and helps 
to maintain telomere length and stability by exerting a 
cis-acting inhibition on telomerase elongation [11, 12]. 
Telomerase is the ribonucleoprotein enzyme responsible 
for polymerization of telomeric DNA required to 
overcome the end-replication problems associated with 
conventional cellular DNA polymerase [13]. Several 
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reports indicated that progressive shortening of telomeric 
DNA in telomerase positive tumors were correlated with 
increasing levels of TRF1 [14]. Increased levels of TRF1 
did not alter the catalytic activity of telomerase but was 
proposed to negatively regulate telomere length through 
steric exclusion of telomerase access to chromosome 
ends [15].
Telomeres and adjacent subtelomeric sequences are 
generally considered to be regions of heterochromatin 
architecture [16, 17]. Similar to other heterochromatic 
regions, subtelomeric chromatin contains several marks of 
histone modifications and dense DNA methylation [18-20]. 
Subtelomeres are enriched with gene promoters, segmental 
duplications, satellite sequences or telomere-like 
interstitial repeat sequences [21, 22]. Ectopic epigenetic 
changes at the subtelomeric regions have been proposed 
to influence several biological pathways or induce 
cellular reprogramming, a detailed mechanism of which 
is yet to be understood [23]. Epigenetic modifications 
at subtelomeres have also been recognized to play an 
important role in telomere integrity and length regulation 
[21, 24]. For example, telomerase expressing cancer cells 
retain a high level of DNA methylation at the subtelomeres 
to maintain their heterochromatic state through repression 
of telomeric-repeat containing transcript (TERRA) [25]. In 
addition, inhibition of global DNA demethylation, which 
results from triple-negative knockout (TKO) of ten-eleven 
translocation methylcytosine dioxygenase (TET) proteins, 
resulted in the elongation of telomere length in mouse 
embryonic stem cells [26]. Furthermore, another line of 
studies reported the positive/negative or no correlation 
between subtelomeric methylation and telomere length 
in different disease models [27, 28]. In summary, studies 
show that DNA methylation of subtelomeric regions 
and epigenetic enzymes play a crucial role in regulation 
of telomere length [29]. However, to date, the effect of 
targeted increase in subtelomeric DNA methylation and 
its effect on telomere length maintenance have not been 
achieved due to the inability to localize methyltransferase 
activity particularly in the site-specific subtelomeric 
regions.
Recent discoveries of optically inducible 
(optogenetic) proteins of plant or microbial origin offer 
tunable methods to modulate the dynamic/kinetic nature 
of specific molecular interactions with spatiotemporal 
precision [30-32]. Herein, we demonstrate active and 
on demand targeting of DNMT3A at the subtelomeric 
DNA regions to increase methylation marks at these 
specific genomic locations in HeLa cells. The optically 
inducible dimerizing protein pair CRY2-CIB1 was fused 
to DNMT3A and TRF1 respectively for this targeting 
strategy. Single molecule fluorescence tools are introduced 
to demonstrate and monitor these optogenetically-induced 
interactions in live single cells. Fluorescence Lifetime 
Imaging Microscopy-based Förster Resonance Energy 
Transfer (FLIM-FRET) analysis was used to determine 
their dynamic intra-nuclear distribution patterns. We 
find that the optogenetic regulatory platform developed 
here can specifically alter the endogenous subtelomeric 
epigenetic status selectively, enabling a process that 
is facile, tunable, and precise. This platform provides 
a biophysical and biochemical route to understand 
epigenetic modulation of subtelomeric methylation and 
its role in telomere length maintenance. In this study, we 
report the effect of light-induced association of optogenetic 
fusion proteins on selective increase in DNA methylation 
levels at subtelomeric regions at the chromosomal ends 
that results in telomere lengthening.
RESULTS
Construction and expression of optogenetic 
fusion proteins, designed to target the 
subtelomeric regions
We designed two constructs expressing fusion 
proteins namely the telomere target construct (TCON) 
and the epigenetic effector construct (ECON) containing 
fluorescent reporters EGFP and mCherry respectively 
(Figure 1a). Additionally, TCON contains the human 
TRF1 linked to the wild type CIB1 (cryptochrome-2-
interacting-basic-helix-loop helix) protein, whereas 
DNMT3A and CRY2PHR (N-terminal photolyase 
homology region domain of CRY2) proteins are present 
in ECON. The optically active CIB1 has a blue-light 
dependent reversible association with CRY2PHR [33]. 
The transient expression of TCON and ECON in HeLa 
cells resulted in the production of full-length fusion 
proteins of 149 and 223 kDa mass respectively (Figure 
1b). Transient co-transfection efficiency with TCON and 
ECON reached up to 70 % in HeLa cells as revealed 
by fluorescence-activated cell sorting (Supplementary 
Figure 1g) analysis. Per design, when expressed 
individually, TCON localized predominantly in the 
nucleus (Figure 1c), while the ECON was expressed in 
both the cytoplasm and nucleus (Supplementary Figure 
1b, 1d). Co-expression of the fusion proteins from 
nucleus were also evidenced by fluorescence imaging 
and DAPI-nucleic acid staining (Figure 1e, 1f). Next, we 
asked whether the expressed TCON would bind to the 
telomeres, using Fluorescence Correlation Spectroscopy 
(FCS), co-localization analysis with TRF2 antibody, 
and a chromatin immunoprecipitation (ChIP) assay. 
A distinct, punctate pattern of EGFP florescence was 
observed in TCON transfected cells compared to the 
diffused distribution in the control cells transfected with 
pure EGFP (Figure 1h and 1j). Two species, one diffusing 
slowly (bound component) and the other rapidly (free 
component) with diffusion coefficients of 5.96 ± 0.58 
and 0.92 ± 0.08 μm2/s respectively were observed in 
TCON positive cells (Figure 1k). The fraction of bound 
TCON in the punctate loci was estimated to be 83.0 ± 
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17.0 %. By contrast, a single freely diffusing species 
with a diffusion coefficient of 11.23 ± 2.06 μm2/s was 
observed in control cells expressing EGFP (Figure 1h, 
1i). FCS data suggests that majority of the TCON was in 
a bound state, possibly to the telomeres through TRF1. 
To confirm the binding of TCON to the telomeres, a 
co-immunostaining assay was performed by utilizing 
the fluorescence from EGFP-TCON construct and a 
fluorescent antibody that binds to the endogenous TRF2 
proteins (a bona fide telomere binding protein [15]. We 
observed a typical, punctate, and overlapping staining 
pattern, which confirmed the co-localization of TRF1 
(derived from TCON constructs) and TRF2 at the 
telomeric foci (Figure 1l, 1m, 1n). To further demonstrate 
specific association of TCON to telomeres, a ChIP assay 
was conducted by isolating DNA bound to TCON by 
immunoprecipitation using anti-GFP antibody. Using the 
isolated DNA as template and telomere specific primers, 
a 123 bp amplicon was obtained by PCR, whereas 
the negative control showed no detectable amplicons 
(Supplementary Figure 2). Overall our results show that 
full-length TCON localizes to the nucleus, and a majority 
of these binds to the telomeres and subtelomeric loci 
characterized by TTAGGG sequences.
Optically induced association of TCON and 
ECON
Blue light induced association of TCON and 
ECON in the transiently co-transfected HeLa cells 
was investigated using FLIM-FRET experiments 
(Supplementary Materials and Methods) followed by a 
co-immunoprecipitation assay. The average fluorescence 
lifetime of EGFP fusion protein in cells expressing TCON 
alone was estimated to be 2.4 ns (Figure 2a). However, in 
the case of cells co-transfected with TCON and ECON, 
the average fluorescence lifetime of EGFP fusions reduced 
from 2.43 ns to 2.06 ns upon exposure to blue-light for 5 
min at 8 mW/cm2 (Figure 2b). This significant reduction 
in fluorescence lifetime can be attributed to the FRET 
effect between EGFP and mCherry of the optically active 
fusion proteins due to the light-induced association/
binding. Such interactions appear to be dependent both 
on time and intensity of illumination because of a similar 
Figure 1: Telomere targeting of TCON and nuclear co-localization with ECON. a. Schematic of the HALO tagged TCON 
and ECON fusion proteins, b. Western blot analysis demonstrates production of intact TCON (~149 kD; lane-1), ECON (~223 kD; lane-2), 
and TCON plus ECON (lane-3) fusion proteins in HeLa cells. Representative images showing the nuclear localization of TCON c. ECON 
d. their co-localization e. and their overlap with DAPI stained nucleic acids f. g. Schematic showing the binding of TCON to the telomeric 
repeat sequences through TRF1. FCS measurements showed the distinct distribution and diffusion pattern of TCON tagged EGFP j, k. in 
comparison to the control EGFP h, i. Co-localization of TCON and TRF2 is revealed using the overlapping fluorescence of EGFP of TCON 
and Alexa-647 TRF2 (m) antibody bound to TRF2 l, m and n. in HeLa cells. Because TRF2 is telomere specific binding protein, the co-
localization of TCON to the same locus reveals the association of TCON with telomeres.
Oncotarget50383www.impactjournals.com/oncotarget
magnitude of FRET response that was observed after 
8 min, when the illumination power was reduced to 1 
mW/cm2 (Supplementary Figure 3) [34]. However, a 
further 10-fold reduction in optical power to 0.01 mW/
cm2 was unable to trigger any detectable interaction 
between the fusion proteins even after long-term exposure 
(Supplementary Figure 4). These data revealed a light-
dependent association of TCON and ECON. This was 
further validated by co-immunoprecipitation (Co-IP) 
using EGFP antibody and analysis of the fractions by 
Western-Blot analysis using DNMT3A specific antibody. 
We have detected the ECON fusion protein (ca. 223 
kDa) from the blue light exposed co-transfected cells 
(Figure 2c, lane-3). In contrast, no ECON fusion protein 
was immunoprecipitated from the co-transfected cells 
deprived of blue light exposure (Figure 2c, lane-2). Cells 
transfected with TCON served as the negative control, and 
did not show presence of DNMT3A (Figure 2c, lane-1). 
Collectively, the FLIM-FRET analysis, the Co-IP data, 
the studies shown in Figure 1, and the continued punctate 
staining pattern after exposure to blue-light show the 
formation of blue light dependent formation of TCON and 
ECON at telomeric and subtelomeric regions.
Induced increase in methylation marks at the 
subtelomeric loci
Initially, the ability to methylate genomic DNA by 
DNMT3A domain situated in the context of the ECON 
fusion was evaluated by measuring the global changes 
Figure 2: Blue light induced association of optogenetic fusion proteins. a. Fluorescence lifetime analysis of EGFP component 
of TCON fusion protein in transiently transfected HeLA cells using FLIM-FRET. Fluorescence lifetime was estimated to be 2.41 ns. b. 
Blue-light induced change in fluorescence lifetime of EGFP component of TCON fusion in the presence of ECON. Representative HeLA 
cells co-transfected with TCON and ECON constructs was exposed to 8 mW/cm2 of blue light for the indicated time periods. Fluorescence 
lifetime decreases from 2.43 ns to 2.06 ns over a 5 min exposure to blue light, due to the FRET between EGFP and mCherry, validating 
the optically induced association of CRY2PHR and CIB1 that are components of TCON and ECON fusions respectively. c. Western blot 
analysis of co-immunoprecipitated fraction from cells transfected with either TCON, or TCON and ECON treated with presence (+) and 
in the absence (-) of blue light. Immunoprecipitation was carried out using EGFP antibody, whereas DNMT3A antibody was used for the 
detection of pulled-down ECON in Western blot. An ECON specific band (ca. 223 kDa) was observed in the blot in the protein fractions 
of co-transfected illuminated cells (lane-3). In contrast, no anti-DNMT3A Ab specific band was detected in cells transfected with TCON 
(lane-1) or co-transfected cells lacking light treatment (lane-2). Data shows that blue-light treatment promotes the formation of complexes 
between TCON and ECON.
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in methylation (Supplementary Figure 5). The overall 
methylation level changed from 1% in mock transfected 
cells to 1.6% in ECON transfected cells indicating catalytic 
activity of DNMT3A in ECON fusion. The schematic in 
Figure 3a and 3b illustrate the proposed changes leading 
to a local increase in concentration of ECON at a telomere 
and adjacent subtelomere due to the blue-light induced 
association with TCON bound to various loci of TTAGGG 
sequences at the chromosomal ends. We hypothesize 
that the localized ECON will increase the methylation 
at CpG loci in the subtelomeric region. The changes in 
methylation level at six different subtelomeric CpG sites 
of chromosomes (Chr.) were quantitatively determined 
after the cells were co-transfected and illuminated for 
different excitation time periods (1 hr, 2 hr, or 4 hr). The 
subtelomeric CpG sites of Chr. 7q, 8q, 16p, 18p, 21q, and 
Xp were selected due to their unique sequences, absence 
of telomere like repeats, lack of sequence gaps and 
varying distance of the CpG sites from the telomeres and 
interstitial TTAGGG sequences [35, 36]. The change in 
the methylation status at the subtelomeric CpG sites of six 
chromosomes (Chr.) in TCON and ECON expressing cells 
exposed to blue-light for the three experimented conditions 
was determined by pyrosequencing method. As expected, 
Figure 3: Blue light induced DNA-methylation at the subtelomeres. Schematic showing that, ECON fusion proteins move freely 
within the nucleus in the absence of light a. however, their accumulation at the telomeric and subtelomeric sites is triggered by blue light 
driven association to the TCON fusion proteins bound to the ends of chromosome b. Analysis of changes in DNA methylation at selected 
subtelomeric CpG sites. The extent of changes in methylation was compared between co-transfected cells that were either untreated or 
illuminated for 1, 2, and 4 hr. Methylation levels were measured by pyrosequencing and expressed as % change at the subtelomeric region 
of chromosome 7q c. 8q d. 16p e. 18p f. 21q g. and Xp h. Varying levels of increase in methylation at distinct CpG loci was observed after 
blue light treatment for 1 hr, 2hr, or 4 hr. compared to the co-transfected (CO) cells without any illumination.
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exposure to blue light caused varying levels of increase 
in methylation at the selected CpG sites (Figure 3c-3h) 
compared to the co-transfected cells without any light 
exposure. For example, we have observed highest level 
of changes in methylation at the following regions: 12% 
at the 2nd CpG position of chr.7q (Figure 3c), 7% at the 1st 
CpG position of chr.8q (Figure 3d), 9% at 1st CpG position 
of Chr.16p (Figure 3e), 19% at 2nd CpG position of Chr. 
18p (Figure 3f), 5% at 8th CpG position of Chr.21q (Figure 
3g) and 12% at the 3rd CpG position of chr.Xp (Figure 
3h). The status of methylation at these subtelomeric CpG 
sites from the mock-transfected and illuminated cells are 
summarized in Supplementary Figure 6. Although the 
maximum changes in methylation were observed from the 
cells illuminated for 4 hr, the levels of increase were not 
dramatically different from the cells illuminated for 1 hr or 
2 hr suggesting that significant methylation occurs during 
shorter duration exposures to blue-light.
Strikingly, CpG sites targeted by the optogenetic 
constructs were methylated only when they are located 
within 5 kb of the adjacent TTAGGG sequence. We did 
not observe any significant increase in the methylation 
level at two distal (> 5 kb) subtelomeric CpG sites of 
Chr. 21q and Chr. Xp, followed by co-transfection and 
illumination (Supplementary Figure 7b and 7c). Moreover, 
the change in methylation at off-target sites was evaluated 
at an additional region far from the subtelomeric sites by 
selecting the promoter of HSPA13 gene located proximal 
to the centromere of chr.21 (Supplementary Figure 7a). 
Although random increase in methylation level was 
observed at certain CpG sites of these regions following 
co-transfection, no further increase in methylation was 
observed upon exposure to blue-light. This suggests 
that methylation at these sites might be independent of 
the association between TCON and ECON. Cumulative 
data also suggests that the methylation level at CpG sites, 
which are proximal (< 5 kb) to TTAGGG sites might be 
specifically subjected to the ECON derived DNMT3A 
activity.
Effect of optically induced methylation on 
telomere length
The potential effect of light-induced subtelomeric 
methylation on telomere length was analyzed for three 
generations of Hela cells subjected to successive cycles 
of light-dark treatments as described in the Materials 
and Methods section (Figure 4a). The changes in mean 
telomere length (TRF) in treatment groups was determined 
with Southern Blot over three generations, compared 
to the initial non-treated cell population (Figure 4b; 
Supplementary Figure 8a). Insignificant changes in 
telomere length were observed in mock transfected cells 
either in the presence or absence of blue light. A slight 
decrease in telomere length was observed in co-transfected 
cells that were not exposed to blue light. The mean TRF 
length (kb) slightly reduced from 5.01 Kb in the Gen-1 
to 4.9 Kb in the Gen-2 and 4.6 Kb in the Gen-3 samples. 
Surprisingly, a more dramatic yet opposite effect was 
observed in co-transfected cells exposed to blue-light, 
where the telomere length progressively increased for 
each generation (5.3 Kb for Gen-1, 5.7 Kb for Gen-2 
and 6.03 Kb for Gen-3) (Figure 4b). Furthermore, we 
verified the increase in telomere length using quantitative 
PCR wherein a similar trend in the change in telomere 
repeats per reaction among the treated groups is observed 
(Supplementary Figure 8b). Moreover, we have evaluated 
the possible changes in telomere length in cells, treated 
individually with either TCON or ECON. We however, 
did not observe any significant changes in telomere length 
followed by the ECON treatment. In comparison, telomere 
lengths decreased gradually in cells, followed by the 
treatment with TCON (Supplementary Figure 9). Because 
HeLa cells are telomerase positive cancer cells, it is 
possible that enhanced subtelomeric methylation induced 
by blue light may have increased the access of telomerase 
to the telomeric DNA. Therefore, the telomerase activity 
was determined from cell extracts of the third generation 
using telomere repeat amplification (TRAP) assay 
(Supplementary Materials and Methods). Supplementary 
Figure 10 show that there were no significant changes 
relative telomerase activity in any of the cell extracts 
tested. Simultaneously, the potential cytotoxic effects of 
blue-light treatment and the co-transfection with TCON 
and ECON constructs were evaluated using a MTT based 
cell proliferation assay (Supplementary Figure 11). A 
14% decrease in cell viability was observed when mock-
transfected cells were exposed to blue light, whereas a 
nominal 3% increase was observed when light treated 
co-transfected cells were compared to mock-transfected 
cells with light exposure. Thus, both light treatment and 
co-transfection of TCON and ECON are likely to have 
relatively little effect on cell viability.
DISCUSSION
Epigenetic modification via DNA methylation can 
cause significant effect on gene expression by exerting 
control over a variety of processes involved in cellular 
maintenance and proliferation [37]. However, artificially 
induced methylation at the selected sites on chromosomes 
presents an assortment of unique challenges. Here, 
by adopting optogenetic-epigenetic manipulation, we 
developed for the first time a tool to selectively increase 
the methylation status of the subtelomeric CpG islands. We 
demonstrate that site-directed methylation of subtelomeric 
regions has the potential to modify the global telomere 
length.
Two constructs were designed to demonstrate the 
light-directed site specific methylation. These constructs 
encode the TCON and the ECON fusion proteins with 
the latter acting as an effector due to the presence of 
DNMT3A. We selected DNMT3A over other DNA 
methyltransferases such as DNMT1 to create additional 
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methylation because of its broader spectrum of activity. 
DNMT1 primarily maintains the methylation status 
at the hemimethylated CpG islands in the genome by 
specifically copying the methylation marks onto daughter 
strands created during replication [38, 39]. Capable of de 
novo methylation, DNMT3A creates methylation marks 
both at the unmethylated and hemimethylated CpG 
dinucleotides in addition to taking part in the maintenance 
of methylation patterns [40-42]. To preferentially localize 
DNMT3A to the subtelomeric regions it was fused to 
CRY2PHR, an optically active domain of CRY2 protein 
in ECON. CRY2PHR is capable of binding to its partner 
CIB1. The CRY2-CIB1 interactions are blue light 
dependent and reversible and have been used in a number 
of optogenetic systems [32, 33, 43]. The association of 
CRY2PHR and CIB1 is also rapid and their association 
kinetics has been characterized in our previous work [44].
In the targeting construct TCON, CIB1 exists as a 
fusion to the DNA binding domain from TRF1, which 
specifically binds to TTAGGG repeats found at telomeres 
and subtelomeres [22, 45]. We selected TRF1 to direct the 
optogenetic proteins selectively to each of the chromosome 
end, since it binds to double stranded telomeric DNA 
repeats that helped to anchor TCON fusion protein to 
the chromosome ends. The blue-light driven association 
between the CRY2PHR and CIB1 domains of ECON 
and TCON is a critical factor in localizing DNMT3A 
to the chromosome ends (Figure 3b). Using a variety 
of techniques, including single molecule fluorescence 
approaches, we demonstrated that the full-length fusion 
proteins localize to the nucleus wherein TCON presents a 
punctate nuclear staining pattern presumably at telomeres. 
FCS analysis showed low rates of diffusion of TCON as 
expected of a telomere binding protein bound to its target. 
Confirmatory evidence for TCON binding to telomeric 
DNA was obtained by isolation of TCON-DNA complexes 
by immunoprecipitation and analysis of bound DNA by 
qPCR. Typical punctate, overlapping staining pattern of 
TCON and TRF2, a telomeric binding marker, suggests 
that TRF1 of TCON and TRF2 are situated in close 
proximity, which strengthens the inference that TCON 
binds specifically to the telomeric repeat sequences. In 
addition, fluorescence lifetime analysis using FLIM-
FRET and Co-IP data demonstrated the association 
Figure 4: Change in telomere length and telomerase activity. Schematic of the light-dark cycle, subjected to three generation 
of cells before telomere length measurement a. Telomere length was evaluated among the replicates of mock transfected (MT) and co-
transfected (CO) cells both in absence or presence of blue light (L) (for 4 hr) over three consecutive generations; using Southern Blotting 
b. Treated cells were incubated for 24 hour of post-illumination, and subjected to telomere length measurements. Telomere length did not 
change significantly among mock transfected cells either in the presence or absence of light. Telomere length slightly decreased in co-
transfected cells without illumination over generations. By contrast, a progressive increase in telomere length was observed for the blue 
light illuminated co-transfected cells. The change in telomere length between light treated and non-light treated CO cells was significant (p 
< 0.05) at the end of 2nd and 3rd generation of treatment.
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between TCON and ECON occurs at the telomere and was 
dependent and sensitive to both time and intensity of blue 
light (Figure 2). Taken together, our data reveals the ability 
to spatiotemporally control the reversible assembly of the 
TCON-ECON complexes at the telomeres.
The demonstrated assembly of ECON-TCON 
complex at the telomeres opens the opportunity to 
localize DNMT3A at additional selective genome specific 
target sites. Although telomeric DNA is not a substrate 
for DNMT3A due to lack of CpG islands, the adjacent 
subtelomeric regions rich in CpG islands, was found 
to be an active target for selective DNA methylation. 
Co-transfection of TCON and ECON increased the 
methylation both globally and at the subtelomeric sites in 
the absence of blue light. For instance, the subtelomeric 
regions of interest and the selected control internal 
genomic region (the HSPA13 gene situated near the 
centromere of chr.21) showed increased methylation 
as detected by pyrosequencing (Supplementary Figure 
7b). The global increase in methylation detected in the 
absence of blue light is likely due to the overexpression 
of ECON from the CMV promoter and the presence of 
the native DNA binding domain of the intact DNMT3A 
of ECON which facilitates DNA binding and methylation 
of any CpG island. Interestingly, the level of methylation 
further increased only in the subtelomeric region but not 
in the interstitial genomic regions, when exposed to blue 
light and not in control regions. We evaluated the changes 
in methylation at six unique subtelomeric regions, which 
are variously distant from the TTAGGG repeat sequence. 
The tested unique regions in Chr. 18p and Chr. 21q were 
proximal (49 bp and 118 bp respectively), whereas in 
Chr. 16p, Chr. 8q, and Chr. Xp they were situated at a 
moderate distance from the TTAGGG sequence (206 
bp, 774 bp, and 839 bp respectively) and in Chr. 7q 
the subtelomeric site was separated as far as 3.86 kb 
away from the TTAGGG repeat. The extent of blue 
light induced subtelomeric methylation varied between 
specific chromosomes as well as between CpG sites 
within individual chromosomes. We have also observed 
that the highest increment of methylation occurred 
at the CpG sites, when illuminated for a longer time 
period (4 hr), compared to the groups illuminated for 
comparatively a shorter period of time (2 hr or 1 hr). 
However, in some CpG sites the changes in methylation 
were not significantly different between the treated 
groups illuminated for different time-span. This 
phenomenon can be explained by the association kinetics 
between TCON and ECON. Although previous studies 
suggest that the interaction of CIB1 and CRY2 occurs 
within few seconds but their dissociation is much slower 
[32, 33]. The local concentration of the bound TCON and 
ECON proteins hence might be higher at the subtelomeric 
sites, which reduces the chance of unassociated (free) 
ECON proteins to assemble at the repeat sequences. 
The extent of optically-induced methylation at the 
subtelomeric sites, variously distant from the TTAGGG 
sequences is unlikely to be exclusively dependent upon 
the distance between the sequenced CpG regions and 
TTAGGG sites, but can be attributed to several factors. 
There might be a possibility that the DNMT effect could 
be more prominent at the hypomethylated regions unlike 
the hypermethylated subtelomeric regions. Additionally, 
due to the dynamic three-dimensional structure and the 
compaction of DNA, even adjacent CpGs may not have 
similar degree of accessibility to the DNMT. Although 
our study demonstrated changes in methylation at six 
subtelomeric sites, such changes are likely occurring 
at other CpG sites of the same chromosome as well as 
other chromosomes. We also show that the extent of 
methylation effects at the subtelomeric CpGs due to 
the assembly of TCON and ECON is dependent on the 
distance between the CpG sites and TTAGGG sequences. 
This ensures specificity of optogenetic targeting. 
Taken together, our study shows that by optogenetic 
targeting of DNMT3A to telomeres we can change the 
methylation level of subtelomeric CpG loci. Previously, 
TALE domain mediated targeting of optogenetic pairs 
to achieve histone modification and DNA demethylation 
at various gene promoters have been reported [32, 46]. 
To our knowledge this is the first report of selective 
modulation of the epigenetic status of subtelomeric 
regions.
Significantly, our studies show two divergent effects 
on telomere length in the presence of the optogenetic 
construct pairs in HeLa cells. We observe slight shortening 
of telomeres in TCON and ECON producing cells in 
the absence of blue light treatment. This reduction in 
telomeric length is consistent with previous studies 
showing overexpression of TRF1 that resulted in a gradual 
and progressive reduction in telomere length in tumor-cell 
line HT1080 and such an effect could be nullified using a 
dominant-negative allele of TRF1 without the telomeric 
DNA binding myb domain [14]. Analogous findings were 
reported for TRF2, a telomere binding protein associated 
with TRF1 [15]. Interestingly, the telomerase activity in 
both these cell lines remains unchanged and therefore 
inhibitory effects were attributed to cis-acting negative 
inhibition of telomere elongation [14].
Juxtaposed with the reduction in telomere length 
is an opposing effect caused by blue light treatment of 
co-transfected cells, namely the progressive increase 
in telomere length. Although, the increase in length of 
telomeres appears to be small (0.9 kb between Gen-1 to 
Gen-3), the increase is significant (p < 0.05) compared 
to co-transfected non-illuminated cells where a decrease 
in telomere length was observed best-possibly due to 
inhibitory effects from the overexpression of TCON 
fusion containing TRF1. We find the expression of ECON 
in co-transfected cells results in global increase in DNA 
methylation. Despite the global increase in methylation, 
a parallel expansion in telomere length was not observed 
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in either individually or co-transfected cells lacking 
light treatment (Figure 4b and Supplementary Figure 
8a). Therefore, the increase in telomere length after 
blue light treatment is likely to be directly related to 
the optically directed assembly of TCON and ECON at 
the telomeres and the abundant increase in methylation 
at subtelomeric regions. Furthermore, we find that the 
increase in subtelomeric methylation does not have any 
effect on telomerase activity in these cells. We propose 
that increased subtelomeric methylation can enhance 
the accessibility of telomerase to telomeric DNA 
either directly or indirectly through the regulation of 
positive and/or negative modulators of telomere length 
homeostasis.
The application of optogenetic tools to cell biological 
studies has allowed unprecedented spatiotemporal control 
in the manipulation of biological networks to extract 
mechanistic insights on cellular processes. To target 
specific DNA loci for epigenetic alterations, various DNA 
interaction domains such as TALE, zinc finger motifs 
have been integrated into the optogenetic tools [32, 46, 
47]. We have expanded the optogenetic tool box by using 
CIB1-CRY2PHR to co-localize DNMT3A and TRF1 at 
the subtelomeric sites to alter the epigenetic state to study 
how epigenetic modulations regulate telomere length. 
Although the utility of our approach was demonstrated 
using the methytransferase DNMT3A, the modular 
design will permit substitution with variety of effectors 
such as other methyltransferases, demethylases, and 
histone modification enzymes to selectively manipulate 
the epigenetic status of chromosomal ends.
Epigenetic modifications are important in 
maintaining the heterochromatic state of telomeric and 
subtelomeric regions which in turn affects the telomere 
length and stability in both normal and cancerous cells 
[18, 20, 21, 25, 35, 48, 49]. Previously, a negative 
correlation between subtelomeric DNA methylation 
and the telomere length and telomeric recombination 
has been established in embryonic stem cells by 
experimental abrogation of DNMTs [20]. In contrast, 
positive correlation between subtelomeric methylation 
and telomere length was observed in a cohort of 
patients, diagnosed with Dyskeratosis congenital 
[27]. We show that selective increase in methylation 
(possibly through ECON) of subtelomeric CpG islands 
in TRF1 overexpressed cells increases the telomere 
length without an increase in telomerase activity. Our 
results support the previous finding that subtelomeric 
methylation might not alter the telomerase activity 
[49]. The observed increase in telomere length hence 
could be considered as a light induced synergistic effect 
from TCON and ECON and independent of telomerase 
activity. Biophysical tools such as optogenetics could 
be used to selectively perturb the epigenetic patterns at 
chromosomal ends to gain deeper mechanistic insights 
into the effect of epigenetic regulation on telomere 
biology of normal and cancer cells.
MATERIALS AND METHODS
Detailed descriptions of all the materials and 
methods, mathematical derivations, and additional results 
are provided in the Supplementary Information.
Design and construction of the optogenetic 
constructs
Optogenetic fusion proteins were generated by 
assembling the coding sequences of the desired proteins 
using standard restriction enzyme digest and ligation to 
the C-terminus of the HALO tag sequence (pHTNHaloTag 
CMV-neo Vector; Promega). EGFP (#23027 from A. 
LeBlanc laboratory), TRF1 (#16058 from T. D. Lange 
laboratory) of TCON and DNMT3A (#35521 from A. 
Riggs laboratory), CRY2-mCherry (#26866 from C. 
Tucker laboratory) of ECON were obtained from the 
Addgene plasmid repository (https://www.addgene.
org/). The full CIB1 coding sequence including the 
flanking restriction sites for EGFP and TRF1 was 
synthesized with Genscript Inc. PCR conditions, PCR 
primers (Supplementary Table 1), sequencing primers 
(Supplementary Table 2) and full length sequence of 
both the constructs can be found in the Supplementary 
Information (Supplementary Sequences 1 and 2).
Cell culture, transfection and microscopy
HeLa cells were seeded (0.7 X 106) in petri-
plates or culture flasks in the presence of DMEM/F-12 
supplemented with 10% FBS, 1% glutamax and 1% 
penicillin-streptomycin (Life Technologies). Cells were 
subcultured five times after revival from the frozen 
stock, before actual experiments. Transient transfection 
was performed using Lipofectamine-LTX according to 
manufacturer’s instructions. While imaging, cells were 
incubated with HBSS buffer (pH adjusted to 7.4 with 2 M 
NaOH) (Supplementary Materials and Methods).
Co-immunostaining assay with TCON and TRF2
Post-transfected (24 hours after transfection) cells 
were fixed with 4% ice cold paraformaldehyde for 15 
min, then permeated with 0.25% Triton X-100 for 30 
min at room temperature. Blocking was performed with 
PBS solution containing 5% goat serum and 0.3% Triton 
X-100 for 1 h. Mouse monoclonal anti-TRF2 antibody 
(ab13579, Abcam) diluted 1:500 was incubated overnight 
with the cells at 4°C. After washing with PBS, goat anti-
mouse secondary antibody conjugated with Alexa647 
diluted 1:1000 was applied for 1 h at room temperature. 
Cells were completely rinsed with fresh PBS prior to 
imaging. Confocal imaging was performed with the 
PicoQuant system where a 465 nm laser was used to 
excite TRF1-GFP and a 633 nm laser was used to excite 
Alexa647.
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Single molecule fluorescence and illumination 
assays
The optogenetic association of ECON and TCON 
in the post-transfected live cells weremonitored with 
single-molecule fluorescence experiments, mostly FLIM-
FRET and FCS (Supplementary Materials and Methods). 
In order to illuminate large populations of cells for the 
downstream biological assays, a mounted high-power 
LED with the peak wavelength at 455 nm (Thorlabs), 
controlled by a DC2100 LED driver, was applied. 
The illumination beam size was adjusted according 
to different surface areas of the culture vessels. Based 
on optimization, the illumination power for all of the 
subsequent experiments was determined to be 1-2 mW/
cm2 for 60 min. At this intensity no cytotoxic effect were 
observed in our studies and is well below the threshold 
level and consistent with the past work on microscopy and 
optogenetics [32, 50].
Co-immunoprecipitation coupled with western 
blot
Co-immunoprecipitation (Co-IP) was conducted 
with the Pierce Co-IP Kit (Thermo Fisher Scientific 
Inc.) as described in our previous study [39]. In brief, 
anti-EGFP monoclonal antibody (ab69314, Abcam) was 
immobilized using the AminoLink Plus coupling resin. 3 
× 106 cells transfected with TCON and ECON were lysed 
(25 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% 
glycerol; pH 7.4) after illumination. About 1 mg of pre-
cleared lysate was incubated overnight with the antibody-
coupled resin at 4°C. After elution, the protein sample 
was analyzed by Western blotting. Western blot assay was 
performed as detailed in the Supplementary Materials and 
Methods, using an anti-DNMT3A antibody (ab23565, 
Abcam). The blot was developed with a secondary Ab 
from rabbit (ab150077; Thermo-Scientific). A 180 kDa 
pre-stained marker (26616; Life Technologies) was used 
as a reference for relative mass.
BSP-PCR and pyrosequencing
The possible effect of light induced assembly of 
TCON and ECON on subtelomeric methylation was 
assessed with pyrosequencing. Changes in methylation 
level were demonstrated at six subtelomeric CpG sites 
from Chr. 7q, 8q, 16p, 18p, 21q, and Xp, which were 
located within 5 kb from the adjacent TTAGGG sequences. 
The changes in methylation level were also determined 
at the subtelomeric sites (at Chr. 21q and Xp), distal 
(>5 kb) to the adjacent TTAGGG sequences and at the 
promoter region of a centromere adjacent gene HSPA13 
at chr.21. These regions served as the negative control to 
the light induced methylation at the TTAGGG proximal 
subtelomeres. Details of the BSP and pyrosequencing 
assays can be found in Supplementary Materials and 
Methods, Results section. BSP-PCR, pyro-sequencing 
primers, PCR reaction conditions and sequences analyzed 
are summarized in the Supplementary Tables 3 and 4.
Measurement of telomere length and telomerase 
activity
To evaluate the subtelomeric methylation effects 
on telomere length, cells expressing TCON and ECON 
were treated in light-dark cycle of 72 hr duration. Briefly, 
cells grown for 24 hr were co-transfected with TCON and 
ECON and allowed to grow for another 24 hr followed by 
a four-hour exposure to blue light. Subsequently, the cells 
were allowed to recover in the dark for 20 hours. Cells 
at the end of this typical cycle of treatment were referred 
to as generation-1 (Gen-1). Genomic DNA was extracted 
from cells of Gen-1 for determining telomere length. An 
aliquot of cells from Gen-1 were subjected to further 
rounds of light-dark cycle treatments as described to yield 
genomic DNA for generation-2 (Gen-2) and generation-3 
(Gen-3). The DNA obtained from Gen-2and Gen-3, were 
actually at an interval of 144 hr. (6 days) and 216 hr. (9 
days) respectively from the initial point of cell propagation 
which were considered the control (non-treated) cells. 
The telomere length was measured by Southern Blotting 
(Supplementary Materials and Methods), and analyzed 
by quantitative PCR analysis [51, 52] from three (n=3) 
independent rounds of experiments. The changes in 
telomere length at each generation were compared to 
the telomere length obtained from the initial non-treated 
control cells. Simultaneously we also evaluated the 
catalytic activity of telomerase with TRAP assay among 
the blue-light treated co-transfected cells from Gen-3 
(Supplementary Materials and Methods).
Statistical analyses
To determine the difference between average mean 
values between control and treated groups, we performed 
a two-tailed student’s t-test. A p-value of < 0.05 was 
considered statistically significant in our analysis.
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